Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Short Interest Update

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) was the target of a large increase in short interest during the month of January. As of January 31st, there was short interest totalling 689,100 shares, an increase of 17.9% from the January 15th total of 584,300 shares. Based on an average daily volume of 225,300 shares, the short-interest ratio is currently 3.1 days. Approximately 2.1% of the shares of the company are short sold.

Institutional Trading of Bioceres Crop Solutions

A number of hedge funds and other institutional investors have recently modified their holdings of BIOX. Bank of America Corp DE increased its holdings in shares of Bioceres Crop Solutions by 186.8% in the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company's stock valued at $35,000 after buying an additional 3,735 shares in the last quarter. Jump Financial LLC acquired a new stake in Bioceres Crop Solutions during the 4th quarter valued at $72,000. Northern Trust Corp purchased a new stake in shares of Bioceres Crop Solutions in the fourth quarter valued at $93,000. Maven Securities LTD acquired a new stake in shares of Bioceres Crop Solutions in the fourth quarter worth $152,000. Finally, Ping Capital Management Inc. grew its holdings in shares of Bioceres Crop Solutions by 7.3% during the fourth quarter. Ping Capital Management Inc. now owns 44,000 shares of the company's stock valued at $268,000 after buying an additional 3,000 shares in the last quarter. Institutional investors own 17.68% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. Lake Street Capital dropped their target price on Bioceres Crop Solutions from $13.00 to $8.00 and set a "buy" rating on the stock in a research report on Friday, February 7th. Oppenheimer dropped their price objective on shares of Bioceres Crop Solutions from $13.00 to $12.00 and set an "outperform" rating on the stock in a report on Tuesday, January 28th. Finally, Canaccord Genuity Group cut their price objective on shares of Bioceres Crop Solutions from $7.00 to $6.50 and set a "buy" rating on the stock in a research report on Thursday, February 13th. Four investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Buy" and an average price target of $9.88.

Bioceres Crop Solutions Stock Performance

Shares of NASDAQ:BIOX traded down $0.12 on Wednesday, hitting $4.71. The company's stock had a trading volume of 245,114 shares, compared to its average volume of 306,294. Bioceres Crop Solutions has a 12 month low of $4.42 and a 12 month high of $13.60. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.96 and a current ratio of 1.33. The company has a market capitalization of $295.37 million, a price-to-earnings ratio of 235.62 and a beta of 0.57. The stock's 50-day moving average is $6.35 and its two-hundred day moving average is $7.47.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.